Shares of Saregama India surged 9.4% on Wednesday, November 4, after company reported a strong set of second-quarter results for the financial year 2026-27, with revenue, net profit and EBITDA registering healthy growth on a year-on-year basis.
The company's consolidated revenue from operations rose 36.5% to ₹314 crore in the second quarter, compared with ₹230 crore in the corresponding quarter last year.
Net profit increased 47.7% to ₹65 crore from ₹44 crore a year ago. EBITDA grew 46.8% to ₹101.3 crore, against ₹69 crore in the year-ago period.
EBITDA margin expanded to 32.3% from 30% in the corresponding quarter last year.
“We continued to build on our growth momentum during the quarter, supported by the performance of our music business and the expansion of our presence across live events and other entertainment formats. Our focus remains on maximising the value of our intellectual property through multiple monetisation avenues, while maintaining financial discipline and investing in opportunities that support sustainable long-term growth.”
AVARNA JAIN, VICE CHAIRPERSON OF SAREGAMA INDIA
Saregama approves voluntary liquidation of two subsidiaries
Separately, the company's board approved the closure, liquidation, dissolution or deregistration of Saregama FZE, Dubai, its wholly-owned subsidiary, in accordance with the applicable requirements of the Jebel Ali Free Zone Authority (JAFZA) and other relevant UAE authorities.
The process will be subject to compliance with applicable Indian laws, including the Foreign Exchange Management Act (FEMA), the overseas investment framework and other regulatory, tax and statutory formalities.
The board also approved a proposal to initiate the voluntary liquidation of Kolkata Metro Networks Limited (KMNL), another wholly owned subsidiary, under Section 59 of the Insolvency and Bankruptcy Code, 2016. The process is subject to shareholder approval at KMNL and completion of the applicable statutory and regulatory requirements.
Saregama shares have gained 21.7% over the past month and are up 71.7% so far this year.
ALso Read: Zydus Lifesciences Q2 Results: Shares fall after profit drops 27%, margins contract
Saregama shares surge 9% as Q2 profit jumps 48% to ₹65 crore, margin expands to 32.3%

1 hour ago
